Compare · BIOS vs PNTM
BIOS vs PNTM
Side-by-side comparison of BioPlus Acquisition Corp. (BIOS) and Pontem Corporation (PNTM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BIOS and PNTM operate in Blank Checks (Finance), so they compete in similar markets.
- PNTM carries a market cap of $838.8M.
BioPlus Acquisition Corp.
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
Pontem Corporation
Pontem Corporation does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest BIOS
- ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by BioPlus Acquisition Corp. (Amendment)
- SEC Form 15-12G filed by BioPlus Acquisition Corp.
- SEC Form 25-NSE filed by BioPlus Acquisition Corp.
- SEC Form RW filed by BioPlus Acquisition Corp.
- Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination
- BioPlus Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Latest PNTM
- SEC Form SC 13G filed by Pontem Corporation
- SEC Form SC 13G/A filed by Pontem Corporation (Amendment)
- SEC Form 15-12G filed by Pontem Corporation
- SEC Form 25-NSE filed by Pontem Corporation
- Pontem Corporation Will Redeem Its Public Shares And Will Not Consummate An Initial Business Combination; Redemption Price For The Public Shares Will Be ~$10.32
- Pontem Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Pontem Corporation will redeem its Public Shares and will not consummate an initial business combination
- SEC Form 10-Q filed by Pontem Corporation
- SEC Form 3 filed by new insider Hagen David
- Pontem Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits